Interferon beta-1b in multiple sclerosis: a seminar in print
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Auckland ; Frankfurt [u.a.]
Adis
1996
|
| Schriftenreihe: | Clinical immunotherapeutics
5,Suppl.1 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 58 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011397287 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970624s1996 |||| 10||| eng d | ||
| 035 | |a (OCoLC)37219076 | ||
| 035 | |a (DE-599)BVBBV011397287 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Interferon beta-1b in multiple sclerosis |b a seminar in print |c guest ed.: C. H. Polman |
| 264 | 1 | |a Auckland ; Frankfurt [u.a.] |b Adis |c 1996 | |
| 300 | |a 58 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Clinical immunotherapeutics |v 5,Suppl.1 | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 4 | |a Interferon |x Therapeutic use | |
| 650 | 4 | |a Interferon-beta |x pharmacology | |
| 650 | 4 | |a Interferon-beta |x therapeutic use | |
| 650 | 4 | |a Multiple Sclerosis |x therapy | |
| 650 | 4 | |a Multiple sclerosis |x Chemotherapy | |
| 650 | 4 | |a Multiple sclerosis |x Immunological aspects | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Polman, Chris H. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007661882 | ||
Datensatz im Suchindex
| _version_ | 1804125910634332160 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011397287 |
| ctrlnum | (OCoLC)37219076 (DE-599)BVBBV011397287 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01151nam a2200349 cb4500</leader><controlfield tag="001">BV011397287</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970624s1996 |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)37219076</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011397287</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interferon beta-1b in multiple sclerosis</subfield><subfield code="b">a seminar in print</subfield><subfield code="c">guest ed.: C. H. Polman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland ; Frankfurt [u.a.]</subfield><subfield code="b">Adis</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">58 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Clinical immunotherapeutics</subfield><subfield code="v">5,Suppl.1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon-beta</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon-beta</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Sclerosis</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple sclerosis</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple sclerosis</subfield><subfield code="x">Immunological aspects</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polman, Chris H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007661882</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV011397287 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:09:04Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007661882 |
| oclc_num | 37219076 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 58 S. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Adis |
| record_format | marc |
| series2 | Clinical immunotherapeutics |
| spelling | Interferon beta-1b in multiple sclerosis a seminar in print guest ed.: C. H. Polman Auckland ; Frankfurt [u.a.] Adis 1996 58 S. txt rdacontent n rdamedia nc rdacarrier Clinical immunotherapeutics 5,Suppl.1 Einzelaufnahme eines Zeitschr.-Suppl. Interferon Therapeutic use Interferon-beta pharmacology Interferon-beta therapeutic use Multiple Sclerosis therapy Multiple sclerosis Chemotherapy Multiple sclerosis Immunological aspects (DE-588)1071861417 Konferenzschrift gnd-content Polman, Chris H. Sonstige oth |
| spellingShingle | Interferon beta-1b in multiple sclerosis a seminar in print Interferon Therapeutic use Interferon-beta pharmacology Interferon-beta therapeutic use Multiple Sclerosis therapy Multiple sclerosis Chemotherapy Multiple sclerosis Immunological aspects |
| subject_GND | (DE-588)1071861417 |
| title | Interferon beta-1b in multiple sclerosis a seminar in print |
| title_auth | Interferon beta-1b in multiple sclerosis a seminar in print |
| title_exact_search | Interferon beta-1b in multiple sclerosis a seminar in print |
| title_full | Interferon beta-1b in multiple sclerosis a seminar in print guest ed.: C. H. Polman |
| title_fullStr | Interferon beta-1b in multiple sclerosis a seminar in print guest ed.: C. H. Polman |
| title_full_unstemmed | Interferon beta-1b in multiple sclerosis a seminar in print guest ed.: C. H. Polman |
| title_short | Interferon beta-1b in multiple sclerosis |
| title_sort | interferon beta 1b in multiple sclerosis a seminar in print |
| title_sub | a seminar in print |
| topic | Interferon Therapeutic use Interferon-beta pharmacology Interferon-beta therapeutic use Multiple Sclerosis therapy Multiple sclerosis Chemotherapy Multiple sclerosis Immunological aspects |
| topic_facet | Interferon Therapeutic use Interferon-beta pharmacology Interferon-beta therapeutic use Multiple Sclerosis therapy Multiple sclerosis Chemotherapy Multiple sclerosis Immunological aspects Konferenzschrift |
| work_keys_str_mv | AT polmanchrish interferonbeta1binmultiplesclerosisaseminarinprint |